Is 7-Hydroxymitragynine (7-OH) legal in Germany?

Legal status

Neither 7-hydroxymitragynine nor kratom is separately scheduled in Germany: 7-OH, a kratom alkaloid, falls outside the BtMG and the NpSG substance groups, so it shares the plant's un-controlled status, reachable only through the Medicines Act (AMG), under which unlicensed commercial sale for human consumption has been barred. [Likely] That finding is carried forward from the entry published before this batch and was not re-derived from statute in this pass. The German position on 7-hydroxymitragynine is not settled by this dossier and the row says so. The search was run across BtMG Anlagen I bis III and NpSG Anlagen 1 und 2 on 20 September 2026 under the terms „7-Hydroxymitragynin; 7-Hydroxymitragynine; 7-OH-Mitragynin“, and it returned no entry; the dossier adds that „Mitragynin“ is not printed as a BtMG table row either, so the parent alkaloid cannot be used to carry the metabolite. What remains open is the medicines route, because AMG § 2 classifies a substance or preparation by its purpose and its pharmacological effect rather than by a list, and that turns on how a particular product is presented. A structural test against NpSG Anlage 1 was also left as a second check rather than concluded. Two different regimes are therefore unresolved here, and neither is being asserted in place of the other.

Consequences if caught

Capital exposure: none. Germany has no death penalty, so that branch is closed whatever the schedule position turns out to be, and it is not open in the way the listing question is. Beyond that the dossier asserts no maximum at all: its penalty column records the position as open and declines to state a ceiling in the absence of a settled substance or product classification. This cell follows that. No BtMG band is stated, because no BtMG line was found and a penalty cannot be built on an absence. No NpSG band is stated either, because nothing has been shown to satisfy an Anlage 1 group, and in that statute a prohibition would have to be established before any offence question could arise.

If prescribed or medical

No prescription position can be given. The substance is in none of the three BtMG Anlagen on this reading, so the marketable and prescribable tier does not arise, and the only route the dossier leaves open is the medicines classification under AMG § 2, which is decided product by product rather than substance by substance. The dossier records no German traveller rule, so this cell defers on both halves and states the deferral rather than supplying a rule.

Documentation

Anyone carrying a kratom-derived preparation containing this alkaloid is carrying an unresolved product, and the documents that would matter are the ones establishing what the product is: composition, presentation and the claims made for it, which are the facts AMG § 2 turns on. The search was run on 20 September 2026 and an absence is only an absence as at the text read.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Germany’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.